Parlodel (Bromocriptine mesylate) for Parkinson's disease

Overview
Parlodel is a prescription drug approved by the Food and Drug Administration (FDA) to treat the symptoms of Parkinson’s. Parlodel is also indicated to treat acromegaly, as well as problems associated with hyperprolactinemia. Parlodel is also referred to by its drug name, bromocriptine mesylate.

Parlodel is used as an adjunctive treatment to levodopa for Parkinson’s. Parlodel is a member of a class of drugs called dopamine agonists. Parlodel is believed to work by increasing the affinity for dopamine in dopamine receptors, allowing the neurotransmitter to have its full effect. This is believed to decrease symptoms of Parkinson’s.

How do I take it?
Prescribing information states that Parlodel is taken orally twice per day.

Parlodel comes in tablet and capsule forms.

Side effects
The FDA-approved label for Parlodel lists common side effects including dizziness, drowsiness, depressed mood, dry mouth, stuffy nose, nausea, vomiting, stomach pain, and loss of appetite.

Rare but serious side effects listed for Parlodel include low blood pressure, hallucinations, inflammation of abdominal organs, and severe allergic reaction.

For more details about this treatment, visit:

Parlodel — GoodRx
https://www.goodrx.com/parlodel/what-is

Parlodel — RxList
https://www.rxlist.com/parlodel-drug.htm